Clinical Trials on Cognition Disorders in Argentina

Total 978 results

Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder

Generalized Anxiety Disorder

Costa Rica, Austria, Croatia, India, Serbia, Mexico, Russian Federation, Finland, Lithuania, Greece, Czechia, Indonesia, Argentina, Slovenia, Spain, Turkey
Sanofi

Completed

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia (GEMS)

Insomnia | Sleep Initiation and Maintenance Disorders

United States, France, Canada, Australia, Germany, Netherlands, Spain, Czech Republic, Mexico, United Kingdom, Argentina, Chile
Circassia Limited
Syneos Health; CIDAL

Completed

Grass Observational Study

Grass Allergy | Rhinoconjunctivitis

United States, Argentina, Chile
Sanofi

Completed

Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes (AFICIONADO)

Diabetes Mellitus, Type 2

Argentina
Sanofi

Completed

Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients (SERENADE)

Type 2 Diabetes Mellitus

United States, Poland, Germany, Netherlands, Argentina, Hungary, Chile
H. Lundbeck A/S

Completed

Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder

Generalized Anxiety Disorder

Chile, Argentina, Colombia, Costa Rica, Estonia, Finland, France, Hungary, Peru, Russian Federation, South Africa
Boehringer Ingelheim

Completed

A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder

Borderline Personality Disorder

Spain, Germany, Sweden, United States, Mexico, Argentina, France, Poland, Australia, Belgium, Bulgaria, Czechia, Denmark, Italy, Japan
Eli Lilly and Company

Completed

A Study in the Treatment of Children and Adolescents With Major Depressive Disorder

Major Depressive Disorder

Mexico, United States, Argentina, Canada
Abbott

Terminated

An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia

Schizophrenia

United States, Argentina, Mexico
Eli Lilly and Company
Alkermes, Inc.

Completed

Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP) (IDAP)

Diabetes Mellitus, Type 2

United States, Argentina, Portugal, South Africa
Novartis Pharmaceuticals

Terminated

Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent

Major Depressive Disorder With Suicidal Ideation With Intent

Taiwan, Spain, Germany, Netherlands, Turkey, Mexico, United States, Malaysia, Poland, Canada, Japan, Russian Federation, Argentina, Brazil
Sanofi

Completed

Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin (ARTEMIS-DM)

Type 2 Diabetes Mellitus

Argentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
Janssen Research & Development, LLC

Recruiting

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE)

Depressive Disorder, Major

United States, Korea, Republic of, Spain, Argentina, Sweden, Germany, Canada, France, Brazil
H. Lundbeck A/S

Completed

Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression (VIVRE)

Major Depressive Disorder

Spain, Czechia, Slovakia, Estonia, Sweden, Argentina, Belgium, Bulgaria, Latvia, Mexico, Russian Federation, Ukraine
Minoryx Therapeutics, S.L.

Recruiting

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy (CALYX)

Cerebral Adrenoleukodystrophy (cALD)

United States, Brazil, Argentina
Janssen Research & Development, LLC

Terminated

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Depressive Disorder, Major

United States, Korea, Republic of, Malaysia, Poland, Finland, Chile, Argentina, Slovakia, Ukraine, Denmark
CENTOGENE GmbH Rostock

Completed

The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease (SWITCH)

Fabry Disease | Anderson-Fabry Disease | Fabry´s Disease

Argentina, Belgium, Croatia, Czechia, Denmark, France, Germany, United Kingdom
Phenox GmbH

Completed

pCONus Treatment of Wide Neck Intracranial Aneurysms (pToWin)

Intracranial Aneurysm

Germany, Argentina, Austria, France, Italy
Shire

Completed

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Major Depressive Disorder

United States, Chile, Australia, Argentina, United Kingdom
Sanofi

Completed

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year (EPLILONG)

Insomnia | Sleep Initiation and Maintenance Disorders

United States, France, Germany, Netherlands, Spain, Czech Republic, Mexico, United Kingdom, Argentina, Austria, Finland, Chile, Canada, Australia
University of Bergen
University of Campinas, Brazil; University of Liverpool; University Medical Center... and other collaborators

Completed

ERANet-LAC CODE: International Care Of the Dying Evaluation

Neoplasms | Quality of Life | Bereavement

Norway, United Kingdom, Germany, Argentina, Brazil, Poland, Uruguay
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women

Depressive Disorder | Depression | Depressive Disorder, Major

Colombia, Mexico, United States, Peru, Chile, Argentina
NeuroVia, Inc.

Withdrawn

Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Adrenoleukodystrophy

X-Linked Adrenoleukodystrophy

Australia, Argentina, United Kingdom, Colombia, Chile, France, Russian Federation, Ukraine
Baxalta now part of Shire

Completed

IMMUNINE Pre-Treatment Study

Hemophilia B

Colombia, Bulgaria, Chile, Poland, Romania, Argentina, Brazil, Czechia, Russian Federation, Ukraine
Inmunova S.A.
Chemo Research; KLIXAR; Linical; Crovelis

Not yet recruiting

Efficacy of INM004 in Children With STEC-HUS

Hemolytic-Uremic Syndrome

Argentina
AstraZeneca

Completed

Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder (SILVER)

Generalized Anxiety Disorder

Sweden, Bulgaria, Czech Republic, France, Mexico, South Africa, Spain, Germany, Romania, Finland, Norway, Argentina, Canada, Denmark, Slovakia
Eli Lilly and Company

Completed

A Study in Prevention of Re-emergence of Depression Symptoms

Major Depressive Disorder

United States, Germany, Italy, Turkey, Russian Federation, Korea, Republic of, Greece, France, Croatia, Romania, Spain, Argentina, Puerto Rico, Belgium, Mexico, Slovakia
University Hospital, Basel, Switzerland
Swiss National Science Foundation

Active, not recruiting

BAsel Syncope EvaLuation (BASEL IX) Study

Syncope

United States, Spain, Switzerland, New Zealand, Argentina, Australia, Germany, Italy, Poland
Janssen Research & Development, LLC

Completed

54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide (Aspire II)

Depressive Disorder, Major

United States, Belgium, Canada, Poland, France, Spain, Brazil, Lithuania, Czechia, Austria, Argentina, Turkey
Eli Lilly and Company

Completed

A Study in Relapse Prevention of Treatment-Resistant Depression

Treatment Resistant Depression

United States, Argentina, Russian Federation, South Africa, India, Turkey, Puerto Rico, Mexico
University of Sao Paulo General Hospital
Brazilian Research In Intensive Care Network; Latin American Intensive Care...

Recruiting

Adherence to Low Tidal Volume in the Transition to Spontaneous Ventilation in Patients With Acute Respiratory Failure (SPIRAL)

Respiratory Insufficiency | Respiration, Artificial | Acute Hypoxemic Respiratory Failure

Chile, Brazil, Argentina, Bolivia, Colombia, Ecuador, Paraguay, Peru, Uruguay, Mexico
Merck KGaA, Darmstadt, Germany

Completed

Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®

Growth Hormone Deficiency | Turner Syndrome

Argentina, Australia, Austria, Canada, France, Germany, Italy, Norway, Russian Federation, Singapore, Spain, Sweden, United Kingdom
Shire

Completed

Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)

Hunter Syndrome | Mucopolysaccharidosis (MPS)

United States, Argentina, Mexico, Spain, United Kingdom
Janssen Research & Development, LLC

Completed

A Study of Paliperidone Palmitate 6-Month Formulation

Schizophrenia

Hong Kong, Poland, Argentina, Russian Federation, Ukraine, Italy
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.

Major Depressive Disorder

Croatia, Brazil, Bulgaria, France, Poland, Russian Federation, South Africa, Hungary, Romania, Ukraine, Argentina, Chile, Slovakia, Colombia, Germany, Serbia, Spain
Christian Medical College, Vellore, India

Unknown

Musculoskeletal Function in Hemophilia

Hemophilia

India, Argentina, Brazil, Egypt, Iran, Islamic Republic of, Singapore, South Africa, Thailand, Venezuela
Pontificia Universidad Catolica de Chile

Unknown

Early CPAP in Respiratory Distress Syndrome

Respiratory Distress Syndrome

Argentina, Chile, Paraguay, Peru, Uruguay
Alkermes, Inc.

Enrolling by invitation

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

Schizophrenia | Bipolar I Disorder

United States, Argentina, Brazil, Colombia, Mexico
GlaxoSmithKline

Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments (DREAMM-20)

Multiple Myeloma

Australia, Poland, Taiwan, Korea, Republic of, Japan, United Kingdom, Brazil, Mexico, Turkey, Argentina
Solvay Pharmaceuticals
Wyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/S

Completed

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Schizophrenia and Schizoaffective Disorder

Hungary, United States, Argentina, Canada, Czech Republic, Estonia, France, Latvia, Lithuania
Sanofi
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]

Diffuse Large B-cell Lymphoma | Classic Hodgkin Lymphoma

Chile, Spain, Argentina
Pfizer

Completed

Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia

Schizophrenia

Germany, Taiwan, Brazil, Philippines, Argentina, Mexico
Pfizer

Completed

Latin American Real-world Study in Acute Leukemia (LOYAL)

Acute Myeloid Leukemia | Acute Lymphoid Leukemia

Argentina, Brazil, Colombia, Chile
Pfizer

Completed

An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy

Familial Amyloid Polyneuropathy | ATTR-PN

Sweden, Brazil, Germany, Argentina, France, Portugal
Janssen-Cilag International NV

Completed

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder (ESCAPE-TRD)

Depressive Disorder, Major

Israel, Hungary, Korea, Republic of, Taiwan, Portugal, Turkey, Germany, Malaysia, Denmark, Bulgaria, Czechia, Belgium, Poland, Brazil, Netherlands, Argentina, Finland, Greece, South Africa, Austria, Kazakhstan, Norway, Sweden, United...
bluebird bio

Completed

A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

Cerebral Adrenoleukodystrophy (CALD)

United States, Germany, Argentina, Australia, France, United Kingdom
Lawson Health Research Institute
Canadian Institutes of Health Research (CIHR); Medtronic; Canadian Critical Care...

Completed

Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study (PROMIZING)

Critically Ill | Acute Respiratory Failure

Canada, Spain, Saudi Arabia, Greece, Italy, France, Argentina
Boehringer Ingelheim

Completed

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Depressive Disorder, Major

Spain, United States, Canada, Germany, Japan, Argentina, Hungary, France, Australia, Bulgaria, Czechia, Poland, Russian Federation, Slovakia
Windtree Therapeutics

Completed

The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)

COVID-19 | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)

United States, Argentina
AstraZeneca

Completed

12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe (GRAVITY)

Atherosclerosis | Hypercholesterolemia | Coronary Heart Disease

Chile, Argentina, Brazil, United States, Colombia, Lithuania, Netherlands, Peru, Venezuela

Clinical Trials on Cognition Disorders in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations